Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: Long-term urodynamic findings

BJU International

Volumn 115, Issue S6, 2015, Pages 33-38

  Schöps, Tim Friedjof ^a   Schneider, Marc P ^a,b   Steffen, Frank ^a   Ineichen, Benjamin V ^b   Mehnert, Ulrich ^a   Kessler, Thomas M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Zurich Brain Research Institute   (Switzerland)

Author keywords

Long term findings; Neurogenic lower urinary tracts dysfunction; Spinal cord injury; Urodynamics

Indexed keywords

BOTULINUM TOXIN A; MUSCARINIC RECEPTOR BLOCKING AGENT;

AGE DISTRIBUTION; AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; ARTICLE; BLADDER COMPLIANCE; CATHETERIZATION; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NEUROGENIC LOWER URINARY TRACT DYSFUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF CARE; SPINAL CORD INJURY; THORACIC SPINAL CORD; URODYNAMICS; VESICOURETERAL REFLUX; COMPLICATION; LOWER URINARY TRACT SYMPTOMS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; URINARY BLADDER, NEUROGENIC;

FEMALE; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPINAL CORD INJURIES; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 84930406069     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13085     Document Type: Article

References (33)

1. Blok B, Pannek J, Castro-Diaz D et al. EAU Guidelines on Neuro-Urology, 2015. Available at: http://uroweb.org/guideline/neuro-urology. Accessed March 2015
2. Gormley EA. Urologic complications of the neurogenic bladder. Urol Clin North Am 2010;37:601-7
3. Hackler RH. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol 1977;117:486-8
4. Lidal IB, Snekkevik H, Aamodt G, Hjeltnes N, Biering-Sorensen F, Stanghelle JK. Mortality after spinal cord injury in Norway. J RehabilMed 2007;39:145-51
5. Soden RJ, Walsh J, Middleton JW, Craven ML, Rutkowski SB, Yeo JD. Causes of death after spinal cord injury. Spinal Cord 2000;38:604-10
6. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-61
7. Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007;26:228-33
8. Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62
9. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78
10. Ditunno JF, Young W, Donovan WH, Creasey G. The International Standards Booklet for Neurological and Functional Classification of Spinal Cord Injury. Paraplegia 1994;32:70-80
11. Schäfer W, Abrams P, Liao L et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-74
12. Gammie A, Clarkson B, Constantinou C et al. International Continence Society guidelines on urodynamic equipment performance. Neurourol Urodyn 2014;33:370-9
13. Edell SL, Kurtz AB, Rifkin MD. Normal renal ultrasound measurements. In Goldenberg BB, Kurtz AB eds, Atlas of Ultrasound Measurements, Chicago: Year Book Medical Publishers, 1990:146
14. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205-9
15. Drake MJ, Cortina-Borja M, Savic G, Charlifue SW, Gardner BP. Prospective evaluation of urological effects of aging in chronic spinal cord injury by method of bladder management. Neurourol Urodyn 2005;24:111-6
16. Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn 2008;27:475-9
17. Hansen RB, Biering-Sorensen F, Kristensen JK. Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury. Spinal Cord 2004;42:631-7
18. Pannek J, Kullik B. Does optimizing bladder management equal optimizing quality of life? Correlation between health-related quality of life and urodynamic parameters in patients with spinal cord lesions. Urology 2009;74:263-6
19. Wöllner J, Kessler TM. Botulinum toxin injections into the detrusor. BJU Int 2011;108:1528-37
20. Novara G, Galfano A, Secco S et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-63
21. Buser N, Ivic S, Kessler TM, Kessels AG, Bachmann LM. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol 2012;62:1040-60
22. Cruz F, Herschorn S, Aliotta P et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 2011;60:742-50
23. Ginsberg D, Gousse A, Keppenne V et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol 2012;187:2131-9
24. Apostolidis A, Dasgupta P, Denys P et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009;55:100-19
25. Abrams P, Agarwal M, Drake M et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int 2008;101:989-94
26. Dahlberg A, Perttila I, Wuokko E, Ala-Opas M. Bladder management in persons with spinal cord lesion. Spinal Cord 2004;42:694-8
27. Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol 2000;38:434-8
28. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2009;56:700-6
29. Wöllner J, Hampel C, Kessler TM. Surgery Illustrated - surgical atlas sacral neuromodulation. BJU Int 2012;110:146-59
30. Kessler TM, La Framboise D, Trelle S et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol 2010;58:865-74
31. Knüpfer SC, Liechti MD, Mordasini L et al. Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction. BMC Urol 2014;14:65
32. Costa P, Perrouin-Verbe B, Colvez A et al. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Eur Urol 2001;39:107-13
33. Sepahpanah F, Burns SP, McKnight B, Yang CC. Role of creatinine clearance as a screening test in persons with spinal cord injury. Arch Phys Med Rehabil 2006;87:524-8